Company Financials

AbCellera Biologics Inc. Financials

United States dollar

business AbCellera Biologics Inc. Company Profile

Main Stock Listing

NASDAQ: ABCL

Market Capitalization $1.03 Billion as of Jan. 1, 2026

Market Cap History

Valuations Metrics as of Jan. 3, 2026

Trailing PE -6.24
Forward PE -4.97
Price to Sales TTM $29.06
Price to Book MRQ $1.06
Enterprise to Revenue 19.06
Enterprise to EBITDA -2.89

Financial Reports as of Sep. 30, 2025

Financials

Fiscal Year Ends 2024-12-31
Most Recent Quarter 2025-09-30
Profit Margin 100.00%
Operating Margin -851.79%
Return on Assets TTM -10.43%
Return on Equity TTM -16.81%

Income Statement

Revenue TTM $35,325,000
Revenue per Share TTM $0.12
Quarterly Revenue Growth 37.60%
Gross Profit TTM $-147,487,008
EBITDA $-232,664,000
Net Income to Common TTM $-171,676,992
Diluted EPS TTM $-0.57
Quarterly Earnings Growth YoY 37.62%

Balance Sheet

Total Cash MRQ $495,672,000
Total Cash per Share MRQ $1.66
Total Debt MRQ $
Total Debt to Equity MRQ 14.75
Current Ratio MRQ 10.10
Book Value per Share MRQ $3.22

Cash Flow

Operating Cash Flow TTM $-104,552,000
Levered Free Cash Flow TTM $-241,470,496

ABCL Stock Info as of Jan. 3, 2026

Stock Statistics

Shares Outstanding 299,011,566
Float Shares 204,326,104
Avg 10 Volume 3,627,560
Avg 30 Volume None
Shares Short 50,505,133
Short Ratio 13.61
Short % of Shares 21.88%
% Held by Insiders 22.97%
% Held by Institutions 36.98%

Stock Price Summary

Beta 0.73
Fifty Two Week Low $1.89
Fifty Two Week High $6.52
Fifty Two Week Change 3.50%
Day 50 MA $4.08
Day 200 MA $3.73

Dividends and Splits

Forward Annual Dividend Rate $
Forward Annual Dividend Yield %
Trailing Annual Dividend Rate $0.00
Trailing Annual Dividend Yield 0.00%
Payout Ratio 0.00%
Dividend Date
Ex Dividend Date
Last Split Factor
Last Split Date